Pourtalebi Jahromi L, Rothammer M, Fuhrmann G (2023)
Publication Type: Journal article, Review article
Publication year: 2023
Book Volume: 200
Article Number: 115028
DOI: 10.1016/j.addr.2023.115028
Lipid-based nanocarriers have been extensively investigated for their application in drug delivery. Particularly, liposomes are now clinically established for treating various diseases such as fungal infections. In contrast, extracellular vesicles (EVs) – small cell-derived nanoparticles involved in cellular communication – have just recently sparked interest as drug carriers but their development is still at the preclinical level. To drive this development further, the methods and technologies exploited in the context of liposome research should be applied in the domain of EVs to facilitate and accelerate their clinical translation. One of the crucial steps for EV-based therapeutics is designing them as proper dosage forms for specific applications. This review offers a comprehensive overview of state-of-the-art polysaccharide-based hydrogel platforms designed for artificial and natural vesicles with application in drug delivery to the skin. We discuss their various physicochemical and biological properties and try to create a sound basis for the optimization of EV-embedded hydrogels as versatile therapeutic avenues.
APA:
Pourtalebi Jahromi, L., Rothammer, M., & Fuhrmann, G. (2023). Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications. Advanced Drug Delivery Reviews, 200. https://dx.doi.org/10.1016/j.addr.2023.115028
MLA:
Pourtalebi Jahromi, Leila, Markus Rothammer, and Gregor Fuhrmann. "Polysaccharide hydrogel platforms as suitable carriers of liposomes and extracellular vesicles for dermal applications." Advanced Drug Delivery Reviews 200 (2023).
BibTeX: Download